Pharmaceutical composition 271

Details for Australian Patent Application No. 2009229204 (hide)

Owner AstraZeneca AB Array Biopharma, Inc.

Inventors Gellert, Paul Richard; Hill, Kathryn Jane; Bateman, Nicola Frances

Agent Davies Collison Cave

Pub. Number AU-B-2009229204

PCT Pub. Number WO2009/118562

Priority 61/040,372 28.03.08 US

Filing date 26 March 2009

Wipo publication date 1 October 2009

Acceptance publication date 24 May 2012

International Classifications

C07D 235/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/4184 (2006.01)

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/118562 Priority application(s): WO2009/118562

24 May 2012 Application Accepted

  Published as AU-B-2009229204

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009229207-Modified loop antenna

2009229200-Intervention method and apparatus